Semin Thromb Hemost 2017; 43(03): 235-241 DOI: 10.1055/s-0037-1601383
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA. 2016 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards
Authors
Author Affiliations
Emmanuel J. Favaloro
1
Department of Haematology, Sydney Centres for Thrombosis and Haemostasis, Institute
of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, Westmead, Australia
References
1 Favaloro EJ. Editorial. Welcome to a special issue of Seminars in Thrombosis & Hemostasis—the
closing issue for 2008. Semin Thromb Hemost 2008; 34: 693-696
2 Favaloro EJ. A tribute to Eberhard F. Mammen, M.D. (1930-2008). Semin Thromb Hemost
2008; 34 (8) 703-707
3 Favaloro EJ. Editorial. Welcome to the first issue of Seminars in Thrombosis and
Hemostasis for 2009. Semin Thromb Hemost 2009; 35: 1-2
4 Favaloro EJ. Editorial. Winners of the Inaugural Eberhard F. Mammen Award for Most
Popular Article. Semin Thromb Hemost 2009; 35: 587-590
5 Favaloro EJ. Editorial. 2009 Eberhard F. Mammen Young Investigator Award Winners.
Semin Thromb Hemost 2010; 36: 469-470
6 Favaloro EJ. Winners of the 2010 Eberhard F. Mammen award for most popular article
during 2008-2009. Semin Thromb Hemost 2010; 36 (7) 685-692
7 Favaloro EJ. 2011 Eberhard F. Mammen award announcements. Semin Thromb Hemost 2011;
37 (5) 431-439
8 Favaloro EJ. 2012 Eberhard F. Mammen award announcements. Semin Thromb Hemost 2012;
38: 425-432
9 Favaloro EJ. Eberhard F. Mammen award announcements. Semin Thromb Hemost 2013; 39:
567-574
10 Favaloro EJ. 2014 Eberhard F. Mammen award announcements: Part I-most popular articles.
Semin Thromb Hemost 2014; 40 (4) 407-412
11 Favaloro EJ. 2014 Eberhard F. Mammen award announcements: Part II-Young Investigator
Awards. Semin Thromb Hemost 2014; 40 (7) 718-723
12 Favaloro EJ. 2015 Eberhard F. Mammen Award Announcements: Part I--Most Popular Articles.
Semin Thromb Hemost 2015; 41 (7) 673-679
13 Favaloro EJ. 2015 Eberhard F. Mammen Award announcements: part II-Young Investigator
Awards. Semin Thromb Hemost 2015; 41 (8) 809-815
14 Favaloro EJ. 2016 Eberhard F. Mammen Award Announcements: Part I - Most Popular Articles.
Semin Thromb Hemost 2016; 42 (4) 325-330
15 Lijfering WM, Flinterman LE, Vandenbroucke JP, Rosendaal FR, Cannegieter SC. Relationship
between venous and arterial thrombosis: a review of the literature from a causal perspective.
Semin Thromb Hemost 2011; 37 (8) 885-896
16 Pels SG. Current therapies in primary immune thrombocytopenia. Semin Thromb Hemost
2011; 37 (6) 621-630
17 Cuker A. Current and emerging therapeutics for heparin-induced thrombocytopenia.
Semin Thromb Hemost 2012; 38 (1) 31-37
18 Jayandharan GR, Srivastava A, Srivastava A. Role of molecular genetics in hemophilia:
from diagnosis to therapy. Semin Thromb Hemost 2012; 38 (1) 64-78
19 Szántó T, Joutsi-Korhonen L, Deckmyn H, Lassila R. New insights into von Willebrand
disease and platelet function. Semin Thromb Hemost 2012; 38 (1) 55-63
20 Salmela B, Joutsi-Korhonen L, Armstrong E, Lassila R. Active online assessment of
patients using new oral anticoagulants: bleeding risk, compliance, and coagulation
analysis. Semin Thromb Hemost 2012; 38 (1) 23-30
21 Aatonen M, Grönholm M, Siljander PR. Platelet-derived microvesicles: multitalented
participants in intercellular communication. Semin Thromb Hemost 2012; 38 (1) 102-113
22 Lacroix R, Dignat-George F. Microparticles: new protagonists in pericellular and
intravascular proteolysis. Semin Thromb Hemost 2013; 39 (1) 33-39
23 McEwen BJ, Morel-Kopp MC, Chen W, Tofler GH, Ward CM. Effects of omega-3 polyunsaturated
fatty acids on platelet function in healthy subjects and subjects with cardiovascular
disease. Semin Thromb Hemost 2013; 39 (1) 25-32
24 Bernard TJ, Armstrong-Wells J, Goldenberg NA. The institution-based prospective inception
cohort study: design, implementation, and quality assurance in pediatric thrombosis
and stroke research. Semin Thromb Hemost 2013; 39 (1) 10-14
25 Italiano Jr JE. Unraveling mechanisms that control platelet production. Semin Thromb
Hemost 2013; 39 (1) 15-24
26 Du VX, Huskens D, Maas C, Al Dieri R, de Groot PG, de Laat B. New insights into the
role of erythrocytes in thrombus formation. Semin Thromb Hemost 2014; 40 (1) 72-80
27 Yee A, Kretz CA. Von Willebrand factor: form for function. Semin Thromb Hemost 2014;
40 (1) 17-27
28 O'Brien SH. Contraception-related venous thromboembolism in adolescents. Semin Thromb
Hemost 2014; 40 (1) 66-71
29 Flood VH. Perils, problems, and progress in laboratory diagnosis of von Willebrand
disease. Semin Thromb Hemost 2014; 40 (1) 41-48
30 Tange JI, Grill D, Koch CD , et al. Local verification and assignment of mean normal
prothrombin time and International Sensitivity Index values across various instruments:
recent experience and outcome from North America. Semin Thromb Hemost 2014; 40 (1)
115-120
31 Chapman K, Yuen S. Therapy for thrombotic thrombocytopenia purpura: past, present,
and future. Semin Thromb Hemost 2014; 40 (1) 34-40
32 Tiede A, Werwitzke S, Scharf RE. Laboratory diagnosis of acquired hemophilia A: limitations,
consequences, and challenges. Semin Thromb Hemost 2014; 40 (7) 803-811
33 Lim W. Thrombotic risk in the antiphospholipid syndrome. Semin Thromb Hemost 2014;
40 (7) 741-746
34 Fernandes S, Carvalho M, Lopes M, Araújo F. Impact of an individualized prophylaxis
approach on young adults with severe hemophilia. Semin Thromb Hemost 2014; 40 (7)
785-789
35 Mancuso ME, Fasulo MR. Thrombin generation assay as a laboratory monitoring tool
during by-passing therapy in patients with hemophilia and inhibitors. Semin Thromb
Hemost 2016; 42 (1) 30-35
36 Tersteeg C, Fijnheer R, Pasterkamp G , et al. Keeping von Willebrand factor under
control: Alternatives for ADAMTS13. Semin Thromb Hemost 2016; 42 (1) 9-17
37 Kumar R, Dunn A, Carcao M. Changing paradigm of hemophilia management: extended half-life
factor concentrates and gene therapy. Semin Thromb Hemost 2016; 42 (1) 18-29
38 Sokol J, Skerenova M, Jedinakova Z , et al. Progress in the understanding of sticky
platelet syndrome. Semin Thromb Hemost 2017; 43 (1) 8-13
39 Jovanovic L, Antonijevic N, Novakovic T , et al. Practical aspects of monitoring
of antiplatelet therapy. Semin Thromb Hemost 2017; 43 (1) 14-23
40 Stanciakova L, Dobrotova M, Jedinakova Z , et al. Monitoring of hemostasis and management
of anticoagulant thromboprophylaxis in pregnant women with increased risk of fetal
loss. Semin Thromb Hemost 2016; 42 (6) 612-621
41 Biss TT. Venous thromboembolism in children: is it preventable?. Semin Thromb Hemost
2016; 42 (6) 603-611
42 Jiménez-Alcázar M, Kim N, Fuchs TA. Circulating extracellular DNA – cause or consequence
of thrombosis?. Semin Thromb Hemost 2017;
43 Silvis SM, Middeldorp S, Zuurbier SM, Cannegieter SC, Coutinho JM. Risk factors for
cerebral venous thrombosis. Semin Thromb Hemost 2016; 42 (6) 622-631
44 Favaloro EJ. 2017 Eberhard F. Mammen Award Announcements: Part I - Most Popular Articles.
Semin Thromb Hemost 2017;
45 Chapman K, Seldon M, Richards R. Thrombotic microangiopathies, thrombotic thrombocytopenic
purpura, and ADAMTS-13. Semin Thromb Hemost 2012; 38 (1) 47-54